Christopher Fillo - Nov 5, 2021 Form 3/A - Amendment Insider Report for DocGo Inc. (DCGO)

Role
Director
Signature
Chris Fillo by Andre Oberholzer as Attorney-in-Fact /s/ Andre Oberholzer
Stock symbol
DCGO
Transactions as of
Nov 5, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
11/12/2021, 06:09 PM
Date Of Original Report
Nov 9, 2021
Next filing
Jan 27, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DCGO Common Stock 4.53M Nov 5, 2021 By 1868 Univeritas Fund LP F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DCGO Options to Purchase Common Stock Nov 5, 2021 Common Stock 32.9K By 1868 Univeritas Fund LP F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The general partner of 1868 Univeritas Fund LP ("Univeritas Fund") is 1868 Univeritas GP, LLC ("Univeritas GP"). Mr. Fillo is an officer of and controls Univeritas GP and may be deemed the beneficial owner of the securities held by Univeritas Fund.
F2 Univeritas Fund holds 51 Options to purchase Common Stock, each exercisable for $5,200 into 645.1452 shares of Common Stock. 34 Options are unvested and vest in two equal annual installments beginning on January 1, 2022. These 51 Options were granted March 19, 2021 and expire March 18, 2031, in each case, as subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by DocGo Inc. on November 5, 2021.

Remarks:

This Form 3/A is to amend the Form 3 filed on November 9, 2021 to reflect indirect beneficial ownership of the reporting person.